Equities

OrganiGram Holdings Inc

OrganiGram Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)2.71
  • Today's Change-0.05 / -1.81%
  • Shares traded418.02k
  • 1 Year change+2.65%
  • Beta1.0802
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Sep 30 2023202320222021
ASSETS
Cash And Short Term Investments3499184
Total Receivables, Net304621
Total Inventory816849
Prepaid expenses118.366.96
Other current assets, total------
Total current assets156222261
Property, plant & equipment, net99260236
Goodwill, net04214
Intangibles, net11142.73
Long term investments147.076.11
Note receivable - long term------
Other long term assets------
Total assets298577554
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.091.001.06
Other current liabilities, total1.34132.75
Total current liabilities225526
Total long term debt3.632.364.88
Total debt4.723.365.95
Deferred income tax03.62--
Minority interest------
Other liabilities, total0.777.7943
Total liabilities276974
SHAREHOLDERS EQUITY
Common stock777770731
Additional paid-in capital------
Retained earnings (accumulated deficit)(505)(262)(251)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.16)(0.08)(0.08)
Total equity272508480
Total liabilities & shareholders' equity298577554
Total common shares outstanding817875
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.